Goldman Sachs
OACC

Goldman Sachs’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Goldman Sachs’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.6M Hold
529,535
– – ﹤0.01% 3589
2025
Q4 		$5.6M Hold
529,535
– – ﹤0.01% 3652
2025
Q3 		$5.57M Hold
529,535
– – ﹤0.01% 3543
2025
Q2 		$5.53M Hold
529,535
– – ﹤0.01% 3317
2025
Q1 		$5.42M Buy
+529,535
New +$5.31M ﹤0.01% 3271

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Goldman Sachs's OACC Position: Q1 2026 in Review

Goldman Sachs held its Oaktree Acquisition Corp III Life Sciences (OACC) position steady in Q1 2026 at 529,535 shares worth $5.6M. The position accounts for ﹤0.01% of the portfolio, ranked #3589.

Goldman Sachs first reported a position in OACC in Q1 2025 and has held it in 5 quarters since. 51 funds tracked by Wall St. Rank hold OACC as of Q1 2026.

  • Goldman Sachs held 529,535 shares of Oaktree Acquisition Corp III Life Sciences worth $5.6M as of Q1 2026.
  • Goldman Sachs left its Oaktree Acquisition Corp III Life Sciences share count unchanged in Q1 2026.
  • Oaktree Acquisition Corp III Life Sciences made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3589 holding.
  • Goldman Sachs first reported a position in Oaktree Acquisition Corp III Life Sciences in Q1 2025 and has held it in 5 quarters since.
  • 51 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.